These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2232204)

  • 21. Marrow transplantation from unrelated HLA-matched volunteer donors.
    Beatty PG; Hansen JA; Anasetti C; Sanders J; Buckner CD; Storb R; Thomas ED
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2993-4. PubMed ID: 2650410
    [No Abstract]   [Full Text] [Related]  

  • 22. [Analysis of chronic graft-versus-host disease after unrelated-donor bone marrow transplantation. Kanazawa University Bone Marrow Transplant Team].
    Takami A; Nakao S; Ueda M; Takamatsu H; Sugimori N; Yamazaki H; Miura H; Ito K; Yamaguchi M; Niki T
    Rinsho Ketsueki; 1995 Jan; 36(1):6-11. PubMed ID: 7715080
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HLA-mismatched bone marrow transplantation in thalassemia.
    Polchi P; Galimberti M; Lucarelli G; Baronciani D; Giardini C; Angelucci E; De Biagi M; Donati M
    Bone Marrow Transplant; 1993; 12 Suppl 1():67-9. PubMed ID: 8374569
    [No Abstract]   [Full Text] [Related]  

  • 24. Helper T-lymphocyte precursor frequency predicts the occurrence of graft-versus-host disease and disease relapse after allogeneic bone marrow transplantation from HLA-identical siblings.
    Leung AY; Kwok J; Lie AK; Chen P; Chen FE; Liang R
    Haematologica; 2001 Jun; 86(6):652-6. PubMed ID: 11418376
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bone marrow transplantation from genetically HLA-nonidentical donors in children with fatal inherited disorders excluding severe combined immunodeficiencies: use of two monoclonal antibodies to prevent graft rejection.
    Jabado N; Le Deist F; Cant A; De Graeff-Meeders ER; Fasth A; Morgan G; Vellodi A; Hale G; Bujan W; Thomas C; Cavazzana-Calvo M; Wijdenes J; Fischer A
    Pediatrics; 1996 Sep; 98(3 Pt 1):420-8. PubMed ID: 8784367
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mixed leukocyte culture reactivity, HLA-DP typing and GVHD.
    Moreau P; Milpied N; Cesbron A; Mahe B; Bignon JD; Harousseau JL
    Bone Marrow Transplant; 1993 Jan; 11(1):85-6. PubMed ID: 8431717
    [No Abstract]   [Full Text] [Related]  

  • 27. Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation.
    Goulmy E; Schipper R; Pool J; Blokland E; Falkenburg JH; Vossen J; Gratwohl A; Vogelsang GB; van Houwelingen HC; van Rood JJ
    N Engl J Med; 1996 Feb; 334(5):281-5. PubMed ID: 8532022
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Bone marrow transplantation in chronic myeloid leukemia].
    Hansz J
    Acta Haematol Pol; 1992; 23(2 Suppl 1):38-48. PubMed ID: 1488871
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Transplantation immunology in allogeneic bone marrow transplantation. The significance of HLA-tissue crossmatching between donors and recipients].
    Egeland T; Thorsby E
    Tidsskr Nor Laegeforen; 1994 Jan; 114(3):319-22. PubMed ID: 8191429
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of KIR ligand incompatibility on the outcome of unrelated donor transplantation: a report from the center for international blood and marrow transplant research, the European blood and marrow transplant registry, and the Dutch registry.
    Farag SS; Bacigalupo A; Eapen M; Hurley C; Dupont B; Caligiuri MA; Boudreau C; Nelson G; Oudshoorn M; van Rood J; Velardi A; Maiers M; Setterholm M; Confer D; Posch PE; Anasetti C; Kamani N; Miller JS; Weisdorf D; Davies SM;
    Biol Blood Marrow Transplant; 2006 Aug; 12(8):876-84. PubMed ID: 16864058
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular techniques for typing unrelated marrow donors: potential impact of molecular typing disparity on donor selection.
    Baxter-Lowe LA
    Bone Marrow Transplant; 1994; 14 Suppl 4():S42-50. PubMed ID: 7728125
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute graft-versus-host disease after bone marrow transplantation with a single HLA-DPB1*1001 mismatch: involvement of different TCRBV subsets.
    Gaschet J; Gallot G; Ibisch C; Lim A; Even J; Vivien R; Hallet MM; Milpied N; Vié H
    Bone Marrow Transplant; 1998 Aug; 22(4):385-92. PubMed ID: 9722075
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources.
    Rocha V; Wagner JE; Sobocinski KA; Klein JP; Zhang MJ; Horowitz MM; Gluckman E
    N Engl J Med; 2000 Jun; 342(25):1846-54. PubMed ID: 10861319
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Graft vs host disease following kidney transplantation using an '0 HLA antigen mismatched' donor.
    Smith DM; Agura ED; Levy MF; Melton LB; Domiati-Saad R; Klintmalm G
    Nephrol Dial Transplant; 2006 Sep; 21(9):2656-9. PubMed ID: 16627604
    [No Abstract]   [Full Text] [Related]  

  • 35. Bone marrow transplantation in children using closely matched related and unrelated donors.
    Vowels MR; Lam Po Tang R; Mameghan H; Honeyman M; Russell S
    Bone Marrow Transplant; 1991 Aug; 8(2):87-92. PubMed ID: 1933063
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of T-cell depletion on the effects of HLA DR beta 1 and DQ beta allele matching in HLA serologically identical unrelated donor bone marrow transplantation.
    Gajewski J; Gjertson D; Cecka M; Tonai R; Przepiorka D; Hunt L; Giralt S; Chan KW; Feig S; Territo M; Andersson B; van Besien K; Khouri I; Fischer H; Babbitt L; Ippolitti C; Schiller G; Lill M; Warkentin D; Neumann J; Petz L; Terasaki P; Champlin R
    Biol Blood Marrow Transplant; 1997 Jun; 3(2):76-82. PubMed ID: 9267667
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomized placebo-controlled trial of lisofylline in HLA-identical, sibling-donor, allogeneic bone marrow transplant recipients. The Lisofylline Marrow Transplant Study Group.
    List AF; Maziarz R; Stiff P; Jansen J; Liesveld J; Andrews F; Schuster M; Wolff S; Litzow M; Karanes C; Dahlberg S; Kirkhart B; Bianco JA; Singer JW
    Bone Marrow Transplant; 2000 Feb; 25(3):283-91. PubMed ID: 10673700
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical study of a new protocol for acute graft-versus host disease prophylaxis in HLA-haploidentical bone marrow transplantation (BMT)].
    Ji SQ; Chen HR; Wang HX; Yan HM; Liu J; Xue M; Zhu L
    Zhonghua Xue Ye Xue Za Zhi; 2003 Aug; 24(8):416-9. PubMed ID: 14642179
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bone marrow transplantation for severe aplastic anemia from donors other than HLA identical siblings: a report of the BMT Working Party.
    Bacigalupo A; Hows J; Gordon-Smith EC; Gluckman E; Van Lint MT; Congiu M; James DC; Barrett AJ; Gmur J; De Planque MM
    Bone Marrow Transplant; 1988 Nov; 3(6):531-5. PubMed ID: 3063321
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bone marrow transplantation for chronic myelogenous leukemia using unrelated donors: the experience at Huddinge Hospital.
    Aschan J; Ringdén O; Ljungman P; Hägglund H; Klaesson S; Dalianis T; Remberger M
    Transplant Proc; 1995 Dec; 27(6):3531-2. PubMed ID: 8540086
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.